Clindamycin Phosphate Patent Expiration
Clindamycin Phosphate was first introduced by Pfizer Inc
Clindamycin Phosphate Patents
Given below is the list of patents protecting Clindamycin Phosphate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cleocin | US6495157 | Intravaginal clindamycin ovule composition |
Jul 20, 2020
(Expired) | Pfizer |
| Clindagel | US6387383 | Topical low-viscosity gel composition |
Aug 03, 2020
(Expired) | Bausch |
| Clindesse | US5993856 | Pharmaceutical preparations and methods for their administration |
Nov 17, 2017
(Expired) | Padagis Us |
| Clindesse | US6899890 | Bioadhesive drug delivery system |
Apr 27, 2023
(Expired) | Padagis Us |
| Clindesse | US9789057 | Pharmaceutical delivery system | Dec 02, 2026 | Padagis Us |
| Evoclin | US7141237 | Pharmaceutical foam |
Feb 03, 2024
(Expired) | Mylan |
| Evoclin | US7374747 | Pharmaceutical foam |
Jan 23, 2024
(Expired) | Mylan |
| Xaciato | US11129896 | Topical formulations and treatments | Sep 22, 2036 | Organon Llc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Clindamycin Phosphate's patents.
Latest Legal Activities on Clindamycin Phosphate's Patents
Given below is the list recent legal activities going on the following patents of Clindamycin Phosphate.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Change in Power of Attorney (May Include Associate POA) | 29 Dec, 2021 | US11129896 |
| Email Notification | 29 Dec, 2021 | US11129896 |
| Correspondence Address Change | 27 Dec, 2021 | US11129896 |
| Patent Issue Date Used in PTA Calculation | 28 Sep, 2021 | US11129896 |
| Recordation of Patent Grant Mailed | 28 Sep, 2021 | US11129896 |
| Email Notification | 09 Sep, 2021 | US11129896 |
| Issue Notification Mailed | 08 Sep, 2021 | US11129896 |
| Application Is Considered Ready for Issue | 25 Aug, 2021 | US11129896 |
| Dispatch to FDC | 25 Aug, 2021 | US11129896 |
| Issue Fee Payment Verified | 23 Aug, 2021 | US11129896 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Clindamycin Phosphate Generics
Several generic applications have been filed for Clindamycin Phosphate. The first generic version for Clindamycin Phosphate was by Pharmacia And Upjohn Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Apr 2, 2024.
Given below is the list of companies who have filed for Clindamycin Phosphate generic.
1. TARO
Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1% | aerosol, foam | Prescription | TOPICAL | AT | Mar 11, 2020 |
| EQ 1% BASE | lotion | Prescription | TOPICAL | AB | Jun 28, 2021 |
2. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | gel | Discontinued | TOPICAL | N/A | Nov 3, 2022 |
3. SOLARIS PHARMA CORP
Solaris Pharma Corp has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Solaris Pharma Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | gel | Prescription | TOPICAL | AB2 | Aug 13, 2021 |
4. VINTAGE PHARMS
Vintage Pharmaceuticals has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Vintage Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Discontinued | TOPICAL | N/A | Jun 28, 1989 |
5. G AND W LABS INC
G And W Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by G And W Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Discontinued | TOPICAL | N/A | Sep 1, 1988 |
6. IGI LABS INC
Igi Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Igi Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Feb 13, 1989 |
7. LOCH
Loch Pharmaceuticals Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Loch.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | May 9, 1988 |
8. SOLOPAK
Solopak Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Solopak.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Mar 17, 1988 |
9. PAI HOLDINGS PHARM
Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Discontinued | TOPICAL | N/A | Dec 30, 2016 |
10. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | gel | Prescription | TOPICAL | AB1 | Apr 2, 2024 |
11. XTTRIUM LABS INC
Xttrium Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Xttrium Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Discontinued | TOPICAL | N/A | Jul 15, 1997 |
12. PFIZER
Pfizer Inc has filed for 1 generic for Clindamycin Phosphate. This eq 150mg base/ml version comes by the name CLEOCIN PHOSPHATE. Given below are the details of the strengths of this generic introduced by Pfizer.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Prescription | INJECTION | AP | Oct 16, 1987 |
13. ENCUBE
Encube Ethicals Private Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Encube.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | lotion | Prescription | TOPICAL | AB | Jan 18, 2022 |
14. MARSAM PHARMS LLC
Marsam Pharmaceuticals Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Marsam Pharms Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Oct 20, 1988 |
15. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Clindamycin Phosphate. Out of these eq 18mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, eq 12mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, eq 6mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Prescription | INJECTION | AP | Sep 24, 2004 |
| EQ 18MG BASE/ML | injectable | Prescription | INJECTION | AP | Apr 5, 2023 |
| EQ 12MG BASE/ML | injectable | Prescription | INJECTION | AP | Apr 5, 2023 |
| EQ 6MG BASE/ML | injectable | Prescription | INJECTION | AP | Apr 5, 2023 |
16. WATSON LABS
Watson Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Mar 5, 1990 |
17. ABBOTT LABS
Abbott Laboratories has filed for 3 different strengths of generic version for Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Abbott Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 12MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Jun 29, 2001 |
| EQ 6MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Jun 29, 2001 |
| EQ 18MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Jun 29, 2001 |
18. FOUGERA PHARMS INC
Fougera Pharmaceuticals Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Prescription | TOPICAL | AT | Jun 5, 1997 |
19. TEVA PARENTERAL
Teva Parenteral Medicines Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Teva Parenteral.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | May 29, 1992 |
20. BOCA PHARMA LLC
Boca Pharmacal Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Boca Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Discontinued | TOPICAL | N/A | Jan 11, 1989 |
21. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Prescription | TOPICAL | AT | Feb 8, 2018 |
22. PHARMACIA AND UPJOHN
Pharmacia And Upjohn Co has filed for 2 different strengths of generic version for Clindamycin Phosphate. Out of these eq 150mg base/ml version comes by the name CLEOCIN PHOSPHATE, eq 1% base version comes by the name CLEOCIN T. Given below are the details of the strengths of this generic introduced by Pharmacia And Upjohn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Approved Prior to Jan 1, 1982 |
| EQ 1% BASE | solution | Discontinued | TOPICAL | N/A | Feb 8, 1982 |
23. ENCUBE ETHICALS
Encube Ethicals Pvt Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Encube Ethicals.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Prescription | TOPICAL | AT | Jan 28, 2019 |
24. BEDFORD
Bedford Laboratories Div Ben Venue Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Bedford.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Jun 30, 1994 |
25. ABRAXIS PHARM
Abraxis Pharmaceutical Products has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Jun 3, 1988 |
26. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Prescription | INJECTION | AP | May 9, 2007 |
27. SAGENT PHARMS INC
Sagent Pharmaceuticals Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Prescription | INJECTION | AP | Sep 30, 2011 |
28. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | gel | Prescription | TOPICAL | AB1 | Feb 10, 2021 |
| 1% | aerosol, foam | Prescription | TOPICAL | AT | Sep 20, 2021 |
29. ALMAJECT
Almaject Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Almaject.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Prescription | INJECTION | AP | Sep 29, 1988 |
30. FOUGERA PHARMS
Fougera Pharmaceuticals Inc has filed for 2 different strengths of generic version for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Fougera Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Discontinued | TOPICAL | N/A | Feb 14, 2006 |
| EQ 2% BASE | cream | Prescription | VAGINAL | AB | Dec 27, 2004 |
31. SANDOZ INC
Sandoz Inc has filed for 3 different strengths of generic version for Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Sandoz Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6MG BASE/ML
(reference standard) | injectable | Prescription | INJECTION | AP | May 31, 2012 |
| EQ 12MG BASE/ML
(reference standard) | injectable | Prescription | INJECTION | AP | May 31, 2012 |
| EQ 18MG BASE/ML
(reference standard) | injectable | Prescription | INJECTION | AP | May 31, 2012 |
32. RISING
Rising Pharma Holding Inc has filed for 4 different strengths of generic version for Clindamycin Phosphate. Out of these eq 6mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, eq 12mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, eq 18mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6MG BASE/ML | injectable | Prescription | INJECTION | AP | Apr 4, 2013 |
| EQ 12MG BASE/ML | injectable | Prescription | INJECTION | AP | Apr 4, 2013 |
| EQ 18MG BASE/ML | injectable | Prescription | INJECTION | AP | Apr 4, 2013 |
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Oct 10, 2017 |
33. BRISTOL MYERS SQUIBB
Bristol Myers Squibb Pharma Co has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Bristol Myers Squibb.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Feb 1, 1989 |
34. BAXTER HLTHCARE CORP
Baxter Healthcare Corp has filed for 3 different strengths of generic version for Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6MG BASE/ML | injectable | Prescription | INJECTION | AP | Jun 28, 2017 |
| EQ 12MG BASE/ML | injectable | Prescription | INJECTION | AP | Jun 28, 2017 |
| EQ 18MG BASE/ML | injectable | Prescription | INJECTION | AP | Jun 28, 2017 |
35. TARO PHARM INDS
Taro Pharmaceutical Industries Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Taro Pharm Inds.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Prescription | TOPICAL | AT | Mar 31, 2004 |
36. NOVAST LABS
Novast Laboratories Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Discontinued | TOPICAL | N/A | Sep 27, 1996 |
37. EPIC PHARMA LLC
Epic Pharma Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | swab | Prescription | TOPICAL | AT | Jun 17, 2010 |
38. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | solution | Discontinued | TOPICAL | N/A | May 29, 2015 |
39. PADAGIS US
Padagis Us Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE
(reference standard) | swab | Prescription | TOPICAL | AT | May 25, 2000 |
40. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1% BASE | gel | Prescription | TOPICAL | AB1 | Sep 19, 2023 |
41. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1%
(reference standard) | aerosol, foam | Prescription | TOPICAL | AT | Mar 31, 2010 |
| EQ 1% BASE | lotion | Prescription | TOPICAL | AB | Mar 8, 2021 |